Recently, the leading life sciences consulting firmTrinity Life SciencesWith the leading pharmaceutical companySanofiPublication of CooperationCompletedA latest research achievement has developed a breakthrough artificial intelligence model,Type 1 diabetes (T1D) can be detected one year before the onset of symptoms.This was a retrospective cohort study, with collaboration between both parties.Develop a predictive machine learning model that can identify individuals at high risk of progressing to Stage 3 T1D.UtilizeUS Market Access & Technology (MMIT) DatasetThe medical claims data and laboratory test results were used to develop two age-specific AI/ML models (0-24 years old and 25+ years old),The research results found that this model maintained higher accuracy compared to traditional T1D screening methods.Trillion-Dollar Diabetes Market: A Hot Track in AI HealthcareAccording to the International Diabetes Federation (IDF) data, among the current global population of adults aged 20-79,The number of people with diabetes has reached 589 million, approximately 1 in every 9 people is affected.In 2024, global diabetes-related medical expenditures exceeded US$1 trillion for the first time.A global chronic metabolic disease, with its high incidence and the severity of complications, has become a major challenge in the public health field. In recent years, large AI models have developed rapidly and made breakthrough progress in disease prediction, diagnosis, treatment optimization, and complication management.The following summarizes some key models for communication:Diabetica：Developed by teams from Shanghai Jiao Tong University and Fudan University, it can provide diagnostic suggestions, medication management, lifestyle interventions, and patient support.Education Services, Medical EducationAccuracy in the field reached 84.4%, surpassing human doctors.
GluFormer：ByNVIDIA, Weizmann ResearchResearch InstituteWait for the machineDevelopment, able to identify individuals at risk of diabetes or with deteriorating blood sugar control before symptoms appear. In a12Year, Involving580In a study of [number] adults, it accurately labeled66%Newly Diagnosed Diabetes Cases and69%Cardiovascular-related mortality cases.
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
DreaMed™ Advisor Pro: FDA-Approved Insulin Dosing AI Medical SoftwareItems that can optimize the basal rate, carbohydrate ratio (CR), and correction factor (CF) settings of a patient's insulin pump.
DeepDR-LLM：Tsinghua University, Shanghai Jiao Tong University and other teamsDeveloped as the world's first multimodal integrated intelligent system featuring a vision-large language model for diabetes diagnosis and treatment.In addition, artificial intelligence technologies such as EyeArt and IDx-DR have been approved and are widely used for screening patients with diabetic retinopathy.
